You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

VITAMIN A PALMITATE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


When do Vitamin A Palmitate patents expire, and when can generic versions of Vitamin A Palmitate launch?

Vitamin A Palmitate is a drug marketed by Arcum, Banner Pharmacaps, and Bel Mar. and is included in five NDAs.

The generic ingredient in VITAMIN A PALMITATE is vitamin a palmitate. There are fifty drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the vitamin a palmitate profile page.

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for VITAMIN A PALMITATE?
  • What are the global sales for VITAMIN A PALMITATE?
  • What is Average Wholesale Price for VITAMIN A PALMITATE?
Summary for VITAMIN A PALMITATE
Drug patent expirations by year for VITAMIN A PALMITATE
Recent Clinical Trials for VITAMIN A PALMITATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Centre de recherche du Centre hospitalier universitaire de SherbrookeN/A
Institut universitaire de cardiologie et de pneumologie de Québec, University LavalN/A
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)Early Phase 1

See all VITAMIN A PALMITATE clinical trials

US Patents and Regulatory Information for VITAMIN A PALMITATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083311-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083981-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Arcum VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083321-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Banner Pharmacaps VITAMIN A PALMITATE vitamin a palmitate CAPSULE;ORAL 083948-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
Bel Mar VITAMIN A PALMITATE vitamin a palmitate INJECTABLE;INJECTION 080819-001 Approved Prior to Jan 1, 1982 DISCN No No ⤷  Subscribe ⤷  Subscribe ⤷  Subscribe
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

VITAMIN A PALMITATE Market Analysis and Financial Projection Experimental

Vitamin A Palmitate Market Dynamics and Financial Trajectory

Market Overview

The vitamin A palmitate market is an integral part of the broader vitamin A market, which is experiencing significant growth driven by various factors.

Market Size and Growth

The vitamin A market, which includes vitamin A palmitate, is projected to grow substantially in the coming years. By 2031, the vitamin A market is expected to reach USD 844.9 million, growing at a compound annual growth rate (CAGR) of 5.1% from 2024 to 2031[1].

Drivers of the Market

Health Consciousness and Nutritional Needs

The increasing health consciousness among consumers, particularly since the COVID-19 pandemic, has boosted the demand for dietary supplements, including vitamin A palmitate. This vitamin is crucial for vision, immune function, and skin health, making it a popular ingredient in health supplements[3].

Therapeutic Applications

Vitamin A palmitate is used in treating various health conditions, such as macular degeneration, and it is also employed in skin and hair care products due to its beneficial effects on skin and mucosa health. This diverse range of applications drives its demand across different sectors[1].

Food and Beverage Fortification

The food and beverage industry is a significant consumer of vitamin A palmitate, as it is used in the fortification of processed foods to restore micronutrients lost during processing. This segment is expected to grow at a CAGR of 5.5% through 2032, driven by the rising demand for fortified foods and beverages[3].

Regional Market Dynamics

North America

North America, particularly the United States and Canada, is a major market for vitamin A palmitate. The region is expected to account for a significant share of the market, driven by robust healthcare infrastructure, high consumer awareness about health and nutrition, and the widespread adoption of preventive healthcare measures. The North America vitamin A market is predicted to exceed USD 235 million by 2032[3].

Asia Pacific

The Asia Pacific region is another key market, characterized by rapid economic growth, increasing health expenditures, and a growing middle-class population willing to spend on nutrition and wellness. Countries like Indonesia, Thailand, and Malaysia are emerging as lucrative markets, supported by local manufacturers and government policies promoting micronutrient fortification[1].

Product Segments

Retinol and Derivatives

Retinol, which includes vitamin A palmitate, is expected to contribute significantly to the market. In 2024, retinol is projected to account for 54.5% of the vitamin A market, driven by its numerous health benefits and its use in various applications, including food, beverages, and dietary supplements[1].

Feed Grade Vitamin A

The feed grade segment, which includes vitamin A palmitate used in animal nutrition, is also growing. This segment is crucial for preventing growth issues in animals and protecting the epithelium in older animals. Major players like BASF SE, Adisseo, and DSM are expanding their presence in emerging countries, contributing to the growth of this segment[3].

Financial Trajectory

Market Valuation

The vitamin A market, which encompasses vitamin A palmitate, is valued at USD 596.5 million in 2024 and is expected to reach USD 844.9 million by 2031. This growth is driven by increasing demand in various sectors, including dietary supplements, food and beverages, and animal feed[1].

Revenue Growth

The feed grade segment of the vitamin A market is expected to grow at a CAGR of 5% from 2023 to 2032, while the food and beverage application segment is projected to grow at a CAGR of 5.5% during the same period. These growth rates indicate a steady and significant increase in revenue for vitamin A palmitate and related products[3].

Challenges and Opportunities

Substitute Products

One of the challenges facing the vitamin A palmitate market is the availability of substitute products, which could potentially hinder market growth. However, the unique benefits and applications of vitamin A palmitate are expected to maintain its market position[1].

Regulatory Landscape

Stringent regulations regarding the use of synthetic vitamin A in food items are expected to drive the demand for clean-label products. This trend presents an opportunity for manufacturers to focus on innovative, compliant products that meet consumer preferences for natural and safe ingredients[1].

Key Players and Innovations

Major Manufacturers

Companies such as DSM, BASF SE, Adisseo, and others are key players in the vitamin A palmitate market. These companies are investing in the development of new vitamin-based products and expanding their presence in emerging markets, which is driving market growth[1][3].

Production Technologies

The production of vitamin A derivatives, including vitamin A palmitate, has evolved significantly since the first synthetic production in 1948. Modern processes include fully catalytic methods and fermentation, which have improved efficiency and yield. These advancements have made the production of vitamin A palmitate more cost-effective and efficient[2].

Conclusion

The vitamin A palmitate market is poised for significant growth, driven by increasing health consciousness, therapeutic applications, and the expanding use in food and beverage fortification. While there are challenges such as the availability of substitute products, the unique benefits and regulatory trends favoring clean-label products present opportunities for market expansion.

Key Takeaways

  • Market Growth: The vitamin A market, including vitamin A palmitate, is expected to reach USD 844.9 million by 2031, growing at a CAGR of 5.1% from 2024 to 2031.
  • Regional Dynamics: North America and Asia Pacific are key regions driving the market growth.
  • Product Segments: Retinol and feed grade segments are significant contributors to the market.
  • Financial Trajectory: The market is expected to see steady revenue growth driven by increasing demand in various sectors.
  • Challenges and Opportunities: The market faces challenges from substitute products but benefits from trends favoring clean-label and natural ingredients.

FAQs

Q: What is the projected market size of the vitamin A market by 2031? A: The vitamin A market is expected to reach USD 844.9 million by 2031[1].

Q: Which region is the largest market for vitamin A? A: North America is the largest and most developed regional market for vitamin A, accounting for 34.5% of the market share in 2024[1].

Q: What are the primary applications of vitamin A palmitate? A: Vitamin A palmitate is used in dietary supplements, food and beverage fortification, and animal feed[1][3].

Q: How has the production of vitamin A derivatives evolved? A: The production has evolved from initial synthetic methods to more efficient processes including fully catalytic methods and fermentation[2].

Q: What are the key drivers of the vitamin A palmitate market? A: The market is driven by increasing health consciousness, therapeutic applications, and the growing demand for fortified foods and beverages[1][3].

More… ↓

⤷  Subscribe

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.